Notify me when CAISSE DES DEPOTS ET CONSIGNATIONS files a new Schedule 13D/G report.
⭐ Subscribe ⭐Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| STLA | Stellantis N.V. | Common Shares, nominal value EUR0.01 per share | 11% | $3,774,769,097 | 393,615,130 | Caisse des Depots | 14 Feb 2025 | ||
| VALN | Valneva SE | Ordinary Shares, nominal value EUR0.15 per share | 10% | $190,686,666 | -$17,818,616 | 19,946,304 | -8.5% | Caisse des depots et consignations | 27 Feb 2026 |
| IPHA | Innate Pharma SA | Ordinary Shares, nominal value EUR0.05 per share | 7.9% | 7,319,429 | Caisse des depots et consignations | 25 Apr 2025 | |||
| DBVT | DBV Technologies S.A. | Ordinary Shares, nominal value EUR0.10 per share | 4.7% | $208,927,156 | -$1,663,524 | 10,898,595 | -0.79% | Caisse des Depots | 05 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|